Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farnaz Zahedifard

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Experimental Parasitology|February 1, 2011
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice modelAzam Bolhassani, Elham Gholami, Farnaz Zahedifard, et al.
Experimental Parasitology|December 29, 2010
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studiesAzam Bolhassani, Tahereh Taheri, Yasaman Taslimi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infectionDelaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases|July 19, 2011
C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c miceDelaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases|October 23, 2013
Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidateSara Dabirian, Yasaman Taslimi, Farnaz Zahedifard, et al.
Plos Pathogens|April 22, 2024
Beyond the VSG layer: Exploring the role of intrinsic disorder in the invariant surface glycoproteins of African trypanosomesHagen Sülzen, Alexander N Volkov, Rob Geens, et al.
Plos Neglected Tropical Diseases|December 19, 2017
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c miceZahra Abdossamadi, Negar Seyed, Farnaz Zahedifard, et al.
Immunotherapy|October 17, 2017
Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c miceZahra Abdossamadi, Tahereh Taheri, Negar Seyed, et al.
Veterinary Parasitology|August 10, 2015
Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasisMehdi Shahbazi, Farnaz Zahedifard, Noushin Saljoughian, et al.
Chemical Biology & Drug Design|December 16, 2021
Active site-based analysis of structural proteins for drug targets in different human CoronavirusesKhadijeh Ahmadi, Farnaz Zahedifard, Ladan Mafakher, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Experimental Parasitology|February 1, 2011
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice modelAzam Bolhassani, Elham Gholami, Farnaz Zahedifard, et al.
Experimental Parasitology|December 29, 2010
Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studiesAzam Bolhassani, Tahereh Taheri, Yasaman Taslimi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 3, 2011
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infectionDelaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases|July 19, 2011
C-terminal domain deletion enhances the protective activity of cpa/cpb loaded solid lipid nanoparticles against Leishmania major in BALB/c miceDelaram Doroud, Farnaz Zahedifard, Alireza Vatanara, et al.
Plos Neglected Tropical Diseases|October 23, 2013
Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidateSara Dabirian, Yasaman Taslimi, Farnaz Zahedifard, et al.
Plos Pathogens|April 22, 2024
Beyond the VSG layer: Exploring the role of intrinsic disorder in the invariant surface glycoproteins of African trypanosomesHagen Sülzen, Alexander N Volkov, Rob Geens, et al.
Plos Neglected Tropical Diseases|December 19, 2017
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c miceZahra Abdossamadi, Negar Seyed, Farnaz Zahedifard, et al.
Immunotherapy|October 17, 2017
Live Leishmania tarentolae secreting HNP1 as an immunotherapeutic tool against Leishmania infection in BALB/c miceZahra Abdossamadi, Tahereh Taheri, Negar Seyed, et al.
Veterinary Parasitology|August 10, 2015
Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasisMehdi Shahbazi, Farnaz Zahedifard, Noushin Saljoughian, et al.
Chemical Biology & Drug Design|December 16, 2021
Active site-based analysis of structural proteins for drug targets in different human CoronavirusesKhadijeh Ahmadi, Farnaz Zahedifard, Ladan Mafakher, et al.
Pageof 5